Weenig Roger H, Sewell Lindsay D, Davis Mark D P, McCarthy James T, Pittelkow Mark R
Department of Dermatology, Mayo Clinic, Rochester, MN 55905, USA.
J Am Acad Dermatol. 2007 Apr;56(4):569-79. doi: 10.1016/j.jaad.2006.08.065. Epub 2006 Dec 1.
Calciphylaxis is characterized by ischemic cutaneous ulceration, high mortality, and ineffective treatment.
We conducted a retrospective study of 64 patients with calciphylaxis (including 49 dialysis patients age- and sex-matched to 98 dialysis controls).
The estimated 1-year survival rate of calciphylaxis was 45.8%. Risk factors for calciphylaxis included obesity, liver disease, systemic corticosteroid use, calcium-phosphate product more than 70 mg(2)/dL(2), and serum aluminum greater than 25 ng/mL. Survival rates were similar for 16 patients who received parathyroidectomy and 47 who did not. An estimated 1-year survival rate of 61.6% was observed for 17 patients receiving surgical debridement compared with 27.4% for the 46 who did not (P = .008).
The study was limited by its retrospective design and there was no control group for the 15 nondialysis cases.
Calciphylaxis is multifactorial and usually fatal. Prevention of calciphylaxis may include correction of risk factors identified in this study. Surgical debridement was associated with improved survival, but parathyroidectomy was not.
钙化防御的特征为缺血性皮肤溃疡、高死亡率及治疗无效。
我们对64例钙化防御患者进行了一项回顾性研究(包括49例年龄和性别与98例透析对照匹配的透析患者)。
钙化防御的估计1年生存率为45.8%。钙化防御的危险因素包括肥胖、肝病、全身性使用皮质类固醇、钙磷乘积超过70mg²/dL²以及血清铝大于25ng/mL。接受甲状旁腺切除术的16例患者与未接受的47例患者的生存率相似。17例接受手术清创的患者估计1年生存率为61.6%,而未接受的46例患者为27.4%(P = .008)。
该研究受其回顾性设计的限制,且15例非透析病例没有对照组。
钙化防御是多因素的,通常是致命的。钙化防御的预防可能包括纠正本研究中确定的危险因素。手术清创与生存率提高相关,但甲状旁腺切除术并非如此。